Clinical trial
Pilot, Proof-of-Concept Study of Sublingual Tizanidine in Children With Chronic…
NCT00287157 · Teva GTC, Industry · Completed
Key facts
| NCT number | NCT00287157 |
|---|---|
| Title | Pilot, Proof-of-Concept Study of Sublingual Tizanidine in Children With Chronic Traumatic Brain Injury (TBI) |
| Official title | A Double-Blind, Randomized, Two-Way Crossover, Comparative Study to Evaluate the Clinical Efficacy and Safety of Novel Sublingual Tizanidine HCl Versus Placebo in Children With Chronic Traumatic Brain Injury |
| Lead sponsor | Teva GTC, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Traumatic Brain Injury |
| Intervention type | Drug |
| Interventions | Sublingual Tizanidine HCl |
| Enrollment | 5 |
| Start date | Dec 1, 2006 |
| Completion | May 1, 2007 |
| First posted | Feb 6, 2006 |
| Last update posted | Jan 21, 2009 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: